Radiation Gadgets' Paper Trail: FDA Update Call
Published Date: 2/18/2026
Notice
Summary
The FDA is updating its paperwork rules for electronic products that emit radiation to keep everyone safe. If you make or sell these products, you might need to provide some info to the government. Comments on these changes are open until March 20, 2026, so now’s the time to speak up!
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
Big Paperwork Burden for Product Makers
If you make, import, assemble, or sell electronic products that emit radiation, you must submit many reports and keep records under 21 CFR parts 1000–1050 using FDA forms (for example, FDA Forms 2579, 2767, 2877, 3628–3663, 3649). FDA estimates annual reporting totals of 981,203 responses requiring 341,676 hours, recordkeeping totaling 3,663,021 records requiring 429,188 hours, and third-party disclosures totaling 42,129 disclosures requiring 15,559 hours.
New Consumer ARO Form Raised Burden Significantly
FDA added a new form (Form FDA 3649C, Consumer Accidental Radiation Occurrence Report) and adjusted respondent counts, which FDA says increased this information-collection burden by 381,821 hours and by 2,135,962 additional responses/records in the overall estimate.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-12167 — Andrew Jonathan Morgan: Final Debarment Order
Andrew Jonathan Morgan is officially banned for 5 years from importing any drugs into the U.S. because he was convicted of a serious crime related to drug importation. He didn’t respond to the FDA’s notice, so the ban started on June 17, 2026, and he can apply to end it anytime. This means no drug imports from him for a while, keeping things safe and legal.
2026-12165 — Medical Devices; Gastroenterology-Urology Devices; Classification of the Ingestible Gastrointestinal Blood Detection Capsule
The FDA is officially putting the ingestible gastrointestinal blood detection capsule into Class II, meaning it now has special safety rules but fewer hurdles than before. This change helps patients get access to this cool, innovative device faster and keeps it safe and effective. The new classification is effective June 17, 2026, and could save time and money for makers and users alike.
2026-12166 — Medical Devices; Radiology Devices; Classification of the Radiological Machine Learning-Based Quantitative Imaging Software With Predetermined Change Control Plan
The FDA is officially putting radiology software that uses machine learning and has a set plan for updates into a safer, easier-to-manage category called Class II. This change helps make sure the software is safe and effective while speeding up patient access to cool new tech. It’s been effective since early 2023, so companies can expect fewer hoops to jump through without extra costs or delays.
2026-11966 — Forms FDA 3542a and FDA 3542: Questions and Answers; Draft Guidance for Industry; Availability
The FDA just dropped a draft guide to help businesses fill out Forms FDA 3542a and FDA 3542 without confusion. If you submit these forms, this guide answers your top questions and makes the process smoother. You’ve got until August 14, 2026, to send in your feedback before the FDA finalizes the guide—no extra costs, just clearer steps!
2026-11998 — Amendment and Revocation of Organizational Information Regulations
The FDA is updating its rules to point everyone to its website for the latest contact and organizational info, ditching old, unnecessary regulations. This makes it easier for the public to find accurate info all in one place, starting June 15, 2026. If you interact with the FDA, expect smoother access with no extra costs or delays.
2026-11760 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Establishment, Maintenance, and Availability of Records; Additional Traceability Records for Certain Foods
The FDA is asking for approval to collect extra records from food businesses that handle certain high-risk foods. This helps track food sources quickly to keep everyone safe. Food companies should get ready to keep and share these new records, and comments on this plan are due by July 13, 2026.
Previous / Next Documents
Previous: 2026-03096 — Agency Information Collection Activities; Proposed Collection; Comment Request; Q-Submission and Early Payor Feedback Request Programs and Medical Device Development Tools
The FDA wants your thoughts on how they collect info for their Q-Submission and Early Payor Feedback programs, which help medical device makers get advice early on. These updates aim to make the process smoother for companies working with the FDA, saving time and possibly money. If you’re involved in medical device development, speak up by March 20, 2026, to help shape these important tools!
Next: 2026-03098 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Regulations Restricting the Sale and Distribution of Cigarettes and Smokeless Tobacco To Protect Children and Adolescents
The FDA is asking for feedback on rules that keep cigarettes and smokeless tobacco away from kids and teens. Tobacco makers, sellers, and advertisers must tell the FDA if they plan to use new types of ads or labels not already approved. Comments are open until March 20, 2026, and this helps make sure tobacco stays out of young hands without adding extra costs.